Imgenex Corp. develops and commercializes novel
reagents for the scientific study of human biology and disease and for the
production of new diagnostic assays and potential therapies of such diseases.
These novel reagents include antibodies, gene and protein expression systems,
and arrays of various cells and tissues for use in studies of functional
genomics. Areas of biological interest at IMGENEX include cancer, apoptosis
(programmed cell death), molecular signaling pathways, cellular aging, and
metabolic and infectious diseases. Our corporate office is located in Sorrento
Valley, in close proximity to the University of California at San Diego, The
Salk Institute and The Scripps Research Institute.